Teva Products: Updated HCPCS Coding Information – 12/19/22

Teva Products: Updated HCPCS Coding Information

Updated HCPCS* Coding Information for Teva Products

Effective January 1, 2023, providers should use the new, permanently assigned HCPCS codes for these products, as shown in the tables below. Old/temporary HCPCS codes should not be used after December 31, 2022. Please update your claims processing system and any applicable coverage policies and fee schedules.^†

Fosaprepitant for Injection

New HCPCS Code	Old HCPCS Code	Strength	Size	NDC Number	New HCPCS Code Description
J1456	J1453	150 mg/Vial	Single-Dose Vial	00591-4385-79	Injection, fosaprepitant (teva), not therapeutically equivalent to J1453, 1 mg

Fulvestrant Injection

New HCPCS Code	Old HCPCS Code	Strength	Size	NDC Number	New HCPCS Code Description
J9393	J9395	250 mg/5 mL (50 mg/mL)	2 Single-Dose Prefilled Syringes	00591-5019-02	Injection, fulvestrant (teva) not therapeutically equivalent to J9395, 25 mg

Pemetrexed Injection

New HCPCS Code	Old HCPCS Code	Strength	Size	NDC Number	New HCPCS Code Description
J9314	J9999 (temporary J code), J9305	1 g/40 mL	Single-Dose Vial	00480-4515-01	Injection, pemetrexed (teva) not therapeutically equivalent to J9305, 10 mg
J9314	J9999 (temporary J code), J9305	100 mg/4 mL	Single-Dose Vial	00480-4516-01	Injection, pemetrexed (teva) not therapeutically equivalent to J9305, 10 mg
J9314	J9999 (temporary J code), J9305	500 mg/20 mL	Single-Dose Vial	00480-4514-01	Injection, pemetrexed (teva) not therapeutically equivalent to J9305, 10 mg

*Healthcare Common Procedure Coding System

^†Note that specific guidance on the submission of the claims offered by the payer supersedes the codes listed, and providers are responsible for the accuracy of any claims, invoices, or related documentation submitted to payers.